These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7001884)

  • 21. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
    Brown JE; Griffin DE; Rothman SW; Doctor BP
    Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.
    O'Brien AD; LaVeck GD; Griffin DE; Thompson MR
    Infect Immun; 1980 Oct; 30(1):170-9. PubMed ID: 7002787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1.
    Fontaine A; Arondel J; Sansonetti PJ
    Infect Immun; 1988 Dec; 56(12):3099-109. PubMed ID: 3053452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shiga toxin from Shigella dysenteriae 1 inhibits protein synthesis in reticulocyte lysates by inactivation of aminoacyl-tRNA binding.
    Brown JE; Obrig TG; Ussery MA; Moran TP
    Microb Pathog; 1986 Aug; 1(4):325-34. PubMed ID: 3334156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of shiga toxin and sonicates of Shigella isolates from children with neurologic manifestation on neuroblastoma cell lines.
    Ashkenazi S; Yuhas Y; Even-Tov S; Kaminsky E; Danon YL
    Isr J Med Sci; 1994 Aug; 30(8):604-10. PubMed ID: 8045741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative microtiter cytotoxicity assay for Shigella toxin.
    Gentry MK; Dalrymple JM
    J Clin Microbiol; 1980 Sep; 12(3):361-6. PubMed ID: 7012172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shiga toxin: purification, structure, and function.
    Donohue-Rolfe A; Acheson DW; Keusch GT
    Rev Infect Dis; 1991; 13 Suppl 4():S293-7. PubMed ID: 2047652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.
    Tzschaschel BD; Klee SR; de Lorenzo V; Timmis KN; Guzmán CA
    Microb Pathog; 1996 Oct; 21(4):277-88. PubMed ID: 8905616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1.
    Lindberg AA; Brown JE; Strömberg N; Westling-Ryd M; Schultz JE; Karlsson KA
    J Biol Chem; 1987 Feb; 262(4):1779-85. PubMed ID: 3543013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shigella toxin and the pathogenesis of shigellosis.
    Keusch GT; Donohue-Rolfe A; Jacewicz M
    Ciba Found Symp; 1985; 112():193-214. PubMed ID: 3847336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cloning and expression of Shiga-toxin gene from Shigella dysenteriae type I].
    Li F; Huang P; Rui X; Huang C
    Wei Sheng Wu Xue Bao; 1991 Dec; 31(6):420-5. PubMed ID: 1814045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Shiga-like toxin in Escherichia coli strains, etiological agents of diarrheal disease.
    Meitert T; Tonciu M; Ciudin L; Pencu E; Mihai I; Nicolescu S
    Arch Roum Pathol Exp Microbiol; 1989; 48(4):293-8. PubMed ID: 2520669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxicity of a shiga toxin A subunit-CD4 fusion protein to human immunodeficiency virus-infected cells.
    al-Jaufy AY; Haddad JE; King SR; McPhee RA; Jackson MP
    Infect Immun; 1994 Mar; 62(3):956-60. PubMed ID: 8112869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunolabelling of Shiga toxin in macrophages infected with Shigella dysenteriae 1.
    Dacosta B; Sansonetti P; Ryter A
    Res Microbiol; 1990 Jun; 141(5):543-9. PubMed ID: 2218059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the SLT-1A toxin operon by a ferric uptake regulatory protein in toxinogenic strains of Shigella dysenteriae type 1.
    Svinarich DM; Palchaudhuri S
    J Diarrhoeal Dis Res; 1992 Sep; 10(3):139-45. PubMed ID: 1430967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile.
    Rothman SW; Brown JE; Diecidue A; Foret DA
    Infect Immun; 1984 Nov; 46(2):324-31. PubMed ID: 6500693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity of Shiga toxin for primary cultures of human colonic and ileal epithelial cells.
    Moyer MP; Dixon PS; Rothman SW; Brown JE
    Infect Immun; 1987 Jun; 55(6):1533-5. PubMed ID: 3570477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method for detecting Shiga toxin and Shiga-like toxin-I in pure and mixed culture.
    Ashkenazi S; Cleary TG
    J Med Microbiol; 1990 Aug; 32(4):255-61. PubMed ID: 2391709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein synthesis in HeLa or Henle 407 cells infected with Shigella dysenteriae 1, Shigella flexneri 2a, or Salmonella typhimurium W118.
    Hale TL; Formal SB
    Infect Immun; 1981 Apr; 32(1):137-44. PubMed ID: 7012026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.